Your Heart Risk Score Is Probably Wrong
New cardiology evidence suggests we’re missing high-risk patients—and treating too late.
On this page
Hook
What if your “low-risk” heart score is wrong?
A major 2025 review in the Journal of the American College of Cardiology suggests that’s not just possible—it’s common.
Context
For decades, cardiovascular prevention has relied on risk calculators.
Age, cholesterol, blood pressure, smoking → plug into a model → decide whether to treat.
But these models were built on population averages—and they miss individual risk.
Now, newer tools are changing the picture:
- Coronary artery calcium (CAC) scans
- Lipoprotein(a)
- Apolipoprotein B (ApoB)
Together, they can reveal hidden risk long before symptoms appear.
Your Take
We’ve built an entire prevention system around thresholds.
Wait until risk crosses a line → then act.
The problem?
Atherosclerosis doesn’t wait.
By the time someone qualifies for treatment, disease is often already established.
The shift happening now is subtle but important:
👉 From reactive thresholds
👉 To early detection and personalised risk
This isn’t about treating everyone earlier.
It’s about treating the right people earlier.
Implications
If this shift holds, it changes how we think about prevention:
- “Low risk” may not mean safe
- Imaging will become routine in borderline cases
- Biomarkers will refine who actually needs treatment
For patients, it means asking better questions:
- Should I get a CAC scan?
- Do I know my ApoB or Lp(a)?
- Is my risk being underestimated?
For clinicians, it means moving beyond checklists.
FAQ
Q: Are current risk calculators useless?
A: No—they’re still useful as a starting point. But they miss individual variation.
Q: Who should consider additional testing?
A: People with borderline risk, family history, or metabolic risk factors.
Q: Does this mean everyone needs a scan?
A: No. The goal is better targeting—not more testing for everyone.
Further Reading
Closing
The future of prevention isn’t more treatment.
It’s better timing.
And right now—we’re often too late.